DermaGold®: Revolutionizing Wound Care with Patented Technology

SoftWave TRT uses patented technology to reach an injured area at the cellular level to successfully turn on the body's natural healing process.

SoftWave’s DermaGold® is at the forefront of advanced wound care, utilizing patented technology to stimulate the body’s natural healing process at the cellular level. This breakthrough approach accelerates healing, making it a game-changer in the treatment of various wound types.

  • Faster wound healing compared to standard care
  • Non-invasive treatment ensures patient comfort
  • Versatile adjunct therapy, effective alone or in combination with other treatments
  • Reduces complications and can lower amputation rates
Softwave wound healing


  • Faster wound healing than the standard of care
  • Non-invasive
  • Adjunct therapy can be used alone or in combination with other Advanced Wound Care
  • Decreases complications and amputation rates


  • FDA Cleared to treat DFUs
  • Reimbursement Pathway with CPT codes 0512T and 0513T
  • Less costly than HBOT, NPWT, Skin Substitutes


  • Fast and easy to use
  • Used in an office/wound clinic/outpatient setting
  • Mobile unit fits seamlessly within wound care clinic
  • Does not require a sterile environment
  • Average treatment time is less than 10 minutes
  • Once-a-week treatment

SoftWave triggers biological responses

SoftWave produces a biological response that accelerates angiogenesis and revascularization which promotes faster wound healing.

SoftWave burn healing
Softwave healing DFU heal
softwave healing trauma
Wound Source Report Cover

Click on the above image to access our White Paper 

SoftWave biological response w wound

SoftWave initiates a more rapid and effective healing phase.

It is thought to work by:

  • Increasing the blood flow to the wounded area
  • Stimulating the neovascularization and growth factors
  • Modulating the inflammatory process
  • Stimulating osteoclasts and fibroblasts to rebuild injured tissue
  • Facilitating resorption of calcification in tendons and ligaments
  • Stimulating the migration of resident stem cells

Trusted and Researched

Click on the research articles to access PDF download
SoftWave Marcus wound research


Click on the article to access PDF download
Addressing change on a cellular level
Softwaves low intensity shock wave technology accelerates healing

Use DermaGold 100® to accelerate healing

Softwave vs hyperbaric
SoftWave wound care continuum

Click the image to download the full continuum PDF

DermaGold: Faster and More Effective Wound Care

DermaGold® offers a superior solution for chronic non-healing wounds with patented technology, leading to better outcomes and higher client satisfaction:

  • Effective: Clinically proven to expedite wound healing, surpassing traditional methods.
  • Proven: FDA cleared for the treatment of Diabetic Foot Ulcers (DFUs), with established reimbursement pathways via CPT codes 0512T and 0513T.
  • Cost-Effective: A more economical solution compared to Hyperbaric Oxygen Therapy (HBOT), Negative Pressure Wound Therapy (NPWT), and skin substitutes.
  • Convenient: Quick and straightforward application with an average treatment time of under 10 minutes, suitable for once-a-week sessions. The mobility of the unit ensures it can be effortlessly integrated into any office, wound clinic, or outpatient setting without the need for a sterile environment.
Doctor in healthcare

FAQs on DermaGold

What makes DermaGold® different from other wound care technologies?

DermaGold® utilizes patented shockwave technology to accelerate natural healing processes at the cellular level, making it a non-invasive, effective treatment for wounds. Unlike traditional therapies, DermaGold® is FDA-cleared for treating Diabetic Foot Ulcers (DFUs), offering a faster, cost-effective solution without the need for a sterile environment. The technology reaches wider and deeper than other options for superior outcomes.

Is DermaGold® suitable for all types of wounds?

While DermaGold® is FDA-cleared specifically for Diabetic Foot Ulcers, its technology is beneficial for a wide range of wounds. Its non-invasive nature and mechanism of action make it a versatile tool in wound care, suitable for adjunct therapy either alone or in combination with other treatments. It’s advisable to evaluate the specific wound type and condition for compatibility.

What are the training and support options available for clinics adopting DermaGold?

Clinics adopting DermaGold® receive comprehensive training and support to ensure seamless integration into their practice. This includes operational training, best practice guidelines, and ongoing clinical support. The goal is to equip clinicians with the knowledge and skills needed to maximize the therapeutic benefits of DermaGold® for their patients.

Looking to Purchase a Shockwave Therapy Machine?

  • Submit a Request

    Fill out our Become a Provider Form to get started with a SoftWave representative

  • Explore Purchase Options

    SoftWave is a GSA contract holder

  • Begin Treating Patients

    SoftWave is easy to operate, does not require a physician, and suitable for use in non-clinical settings

Looking to Purchase a SoftWave Therapy Device?
Looking to try SoftWave Therapy?